BIOMAT Database Logo BIOMAT Database Logo

[Consumption of psychotropic drugs after implantation of a cardiac defibrillator]. 1999

T Baubet

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D017147 Defibrillators, Implantable Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes. Cardioverter-Defibrillators, Implantable,Implantable Cardioverter Defibrillator,Implantable Cardioverter-Defibrillators,Implantable Defibrillators,Cardioverter Defibrillator, Implantable,Cardioverter Defibrillators, Implantable,Cardioverter-Defibrillator, Implantable,Defibrillator, Implantable,Defibrillator, Implantable Cardioverter,Defibrillators, Implantable Cardioverter,Implantable Cardioverter Defibrillators,Implantable Cardioverter-Defibrillator,Implantable Defibrillator

Related Publications

T Baubet
Cardiac arrhythmias after psychotropic drugs.
August 1977, The American journal of cardiology,
T Baubet
Pneumomediastinum after implantable cardiac defibrillator implantation.
February 2011, European heart journal,
T Baubet
[Consumption of psychotropic drugs by cardiac patients (epidemiological research)].
January 1982, Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina),
T Baubet
Implantable cardiac defibrillator leads dysfunction after LVAD implantation.
November 2020, Pacing and clinical electrophysiology : PACE,
T Baubet
Predicting outcome after cardiac resynchronisation therapy defibrillator implantation: the cardiac resynchronisation therapy defibrillator Futility score.
July 2022, Heart (British Cardiac Society),
T Baubet
[Consumption of psychotropic drugs in Tunisia].
October 1995, La Tunisie medicale,
T Baubet
Consumption of psychotropic drugs in Sweden.
May 1973, Activitas nervosa superior,
T Baubet
Outcomes after transvenous defibrillator implantation in cardiac sarcoidosis: A systematic review.
October 2022, Journal of arrhythmia,
T Baubet
Psychotropic drugs in Australia: consumption patterns.
November 1990, The Medical journal of Australia,
T Baubet
Cardiac risk of psychotropic drugs.
October 2002, The Australian and New Zealand journal of psychiatry,
Copied contents to your clipboard!